Tofilon PJ - Search Results

1

Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.

Dote H, Cerna D, Burgan WE, Carter DJ, Cerra MA, Hollingshead MG, Camphausen K, Tofilon PJ. Dote H, et al. Among authors: tofilon pj. Clin Cancer Res. 2005 Jun 15;11(12):4571-9. doi: 10.1158/1078-0432.CCR-05-0050. Clin Cancer Res. 2005. PMID: 15958643

2

Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment.

Russell JS, Lang FF, Huet T, Janicot M, Chada S, Wilson DR, Tofilon PJ. Russell JS, et al. Among authors: tofilon pj. Cancer Res. 1999 Oct 15;59(20):5239-44. Cancer Res. 1999. PMID: 10537303

3

Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.

Kishi K, Petersen S, Petersen C, Hunter N, Mason K, Masferrer JL, Tofilon PJ, Milas L. Kishi K, et al. Among authors: tofilon pj. Cancer Res. 2000 Mar 1;60(5):1326-31. Cancer Res. 2000. PMID: 10728694

4

Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.

Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ. Petersen C, et al. Among authors: tofilon pj. Clin Cancer Res. 2000 Jun;6(6):2513-20. Clin Cancer Res. 2000. PMID: 10873107

5

Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization.

Russell JS, Raju U, Gumin GJ, Lang FF, Wilson DR, Huet T, Tofilon PJ. Russell JS, et al. Among authors: tofilon pj. Cancer Res. 2002 Apr 15;62(8):2318-26. Cancer Res. 2002. PMID: 11956090

6

Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.

Palayoor ST, Tofilon PJ, Coleman CN. Palayoor ST, et al. Among authors: tofilon pj. Clin Cancer Res. 2003 Aug 1;9(8):3150-7. Clin Cancer Res. 2003. PMID: 12912967

7

Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.

Russell JS, Burgan W, Oswald KA, Camphausen K, Tofilon PJ. Russell JS, et al. Among authors: tofilon pj. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3749-55. Clin Cancer Res. 2003. PMID: 14506167

8

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ. Russell JS, et al. Among authors: tofilon pj. Cancer Res. 2003 Nov 1;63(21):7377-83. Cancer Res. 2003. PMID: 14612536

9

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, Tofilon PJ. Camphausen K, et al. Among authors: tofilon pj. Cancer Res. 2004 Jan 1;64(1):316-21. doi: 10.1158/0008-5472.can-03-2630. Cancer Res. 2004. PMID: 14729640

10

In vivo tumor imaging using a near-infrared-labeled endostatin molecule.

Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K. Citrin D, et al. Among authors: tofilon pj. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):536-41. doi: 10.1016/j.ijrobp.2003.09.068. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters